A dozen infectious pathogens contribute to cancer. Finding ways to prevent them could help millions avoid a cancer diagnosis.
Teens taking daily HIV pills are more likely to have a viral rebound than those on injectable antiretroviral therapy.
An estimated $1.35 billion for TB, HIV, malaria, and maternal and child health is set to expire on September 30.
1 in 60 adults in Fiji is HIV-positive.
In a phase 3 clinical trial, a once-weekly oral HIV treatment maintained viral suppression as effectively as a standard once-daily regimen.
Donor government funding for the global HIV response fell by $2.1 billion in 2025, a decline driven by the US government.
A new work requirement rule goes into effect in January. Experts anticipate higher rates of HIV transmission.
More people with HIV are living into their 70s and 80s, and that has implications for Medicare spending.
Cancer advocates are working to educate doctors and patients about the need for screening for human papillomavirus and early treatment of anal precancers.
Two years after the FDA approved long-acting treatment, 97% of beneficiaries still used daily oral medications.
